Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
about
Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptorSignal transducer and activator of transcription 5A/B in prostate and breast cancersEffective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormoneAntagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissuesGrowth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer.Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxelGrowth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists.Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor.Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinasesNew therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones.Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancersExpression of lymphocyte-derived growth hormone (GH) and GH-releasing hormone receptors in aging rats.Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors.Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer.Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors.Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models.Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive.
P2860
Q24309176-7870A939-3035-453D-852F-852CB5F53E5EQ28281791-3E1E89E6-D8DE-4A54-ABDF-7A4D380BF98CQ33906715-45D6D12B-9F76-4456-8A25-2DE354950471Q33927273-3D0DBB7B-45CF-4DF7-B8D7-4137BBAD33F2Q33933907-A533F53A-88B2-484A-8155-6392F49BD8C8Q34154583-6C99E18D-36AF-426D-9FB0-F4C316F42847Q34161110-3B73174E-9303-40B4-BC2C-CBB7891AC625Q34330174-4EE4B1DD-F612-4079-8A1C-46430A7461F0Q35012937-7376A010-C20D-43FC-8DC6-47A18BE4BEBBQ35080727-62C55F07-BB4B-47E6-B771-2B64D3A1AA9BQ35185769-82D5C68E-C5E6-4A46-ADBE-3984D1A30F92Q35629436-0878CBFA-C6E9-4592-BE4A-8B9D8061F0E8Q35720666-28EF064D-4DEC-44B4-9519-0AFBBB886DB9Q35749794-D627A140-ABFB-4376-B829-AC1B88F0B75EQ36748502-3F4FA20B-AE34-4697-929C-EDCA865A124CQ36862773-5653CD00-D618-4682-B33B-70AB7878CBD5Q37077441-2CA407D9-C3B7-444D-A619-1602153C1620Q37278402-F352F690-7BAA-4485-B92F-62682DA32DEBQ37519616-19D90D5B-25E2-4F3A-81AC-A98E14AD13A4Q37589369-5A576BE1-401C-4274-8C5F-07C58BAE3F46Q38977467-0EB1DD21-7D9A-426B-9379-FDE8D7F9C6AEQ39499342-25E96E09-6111-4E69-B288-76FC331A10EAQ40430581-96A47F97-514B-49E3-AD34-CBFF2732FB97Q48749343-1F67FD75-60A3-4D20-9672-0A80F4A8D7BBQ48828353-C1597AE1-E937-40DF-9DA0-BE6182B360C6Q54381032-3ADD4E96-0B3A-4E33-B6A3-8751B2014A3D
P2860
Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Expression of growth hormone-r ...... ants in human prostate cancer.
@en
Expression of growth hormone-r ...... ants in human prostate cancer.
@nl
type
label
Expression of growth hormone-r ...... ants in human prostate cancer.
@en
Expression of growth hormone-r ...... ants in human prostate cancer.
@nl
prefLabel
Expression of growth hormone-r ...... ants in human prostate cancer.
@en
Expression of growth hormone-r ...... ants in human prostate cancer.
@nl
P2093
P50
P356
P1476
Expression of growth hormone-r ...... iants in human prostate cancer
@en
P2093
Jozsef L Varga
Magdalena Krupa
Zoltan Rekasi
P304
P356
10.1210/JC.2002-020347
P407
P577
2002-10-01T00:00:00Z